摘要
目的了解辽宁医学院附属第一医院2009—2011年3年间临床分离的革兰阳性菌株的分布及耐药情况,指导临床合理使用抗菌药物。方法对所分离的革兰阳性菌株采用最低抑菌浓度(MIC)法进行药敏试验,按美国临床实验室标准化研究所(CLSI)2011年标准判定药敏试验结果,并用WHONET 5.6软件进行数据分析。结果共分离出非重复革兰阳性菌718株,其中葡萄球菌属495株(占68.94%),肠球菌属212株(占29.53%),链球菌属11株(占1.53%)。革兰阳性菌的检出部位来自尿液187株(占26.04%)、痰液164株(占22.84%)、创口分泌物113株(占15.74%)、血液78株(占10.86%)。耐甲氧西林金黄色葡萄球菌(MRSA)和耐甲氧西林凝固酶阴性葡萄球菌(MRCNS)的检出率分别为33.3%(51/153)和84.7%(288/340),未发现对万古霉素耐药的葡萄球菌属;未发现对哌拉西林/他唑巴坦及阿莫西林/克拉维酸耐药的屎肠球菌;万古霉素耐药肠球菌(VRE)分离率仍很低,粪肠球菌和屎肠球菌分别为5.0%(5/101)和5.1%(5/99);屎肠球菌对多数药物的耐药率均高于粪肠球菌。结论革兰阳性菌耐药形势严峻,应重视细菌耐药性监测及抗菌药物的合理使用。
Objective To investigate the distribution and the antimicrobial resistance of Gram- positive bacteria in the First Hospital Affiliated to Liaoning Medical University in China from 2009 to 2011. Methods Antimicrobial susceptibility testing were carried out in the strains of Gram- positive bacteria with minimum inhibitory concentration( MIC) and the data were analyzed by WHONET 5. 6 software according to CLSI 2011 Standards. Results A total of 718 clinical isolates of Gram- positive bacteria were collected including 495 strains of Staphylococci( 68. 94%),212 strains of Enterococci( 29. 53%),and 11 strains of Streptococci( 1. 53%). Among all 718 strains of Gram- positive bacteria,26. 04%( 187 /718) were isolated from urine specimens,22. 84%( 164 /718) from sputum specimens,15. 74%( 113 /718) from wound secretion,and 10. 86%( 78 / 718) from blood specimens. The prevalence of Methicillin- resistant S. aureus( MRSA) and Methicillin- resistant coagulase-negative S. aureus( MRCNS) were 33. 3%( 51 /153) and 84. 7%( 288 /340),respectively. There were no Staphylococcus strains resistant to vancomycin and no Enterococcus strains resistant to piperacillin / tazobactam or Amoxicillin / clavulanic acid. The resistance rates of Enterococci to vacomycin were very low,the its rates in E. faecalis and E. faecium were 5. 0%( 5 /101) and 5. 1%( 5 /99),respectively. The resistance rates of E. faecium strains to most tested drugs were higher than those of E. faecalis. Conclusion The antimicrobial resistance rates of Gram- positive bacteria are high,which has been a big challenge for healthcare management. We should pay more attention to monitoring the drug resistance of these bacteria and enhancing the rational use of antibiotics.
出处
《中国全科医学》
CAS
CSCD
北大核心
2013年第31期3738-3741,共4页
Chinese General Practice
基金
辽宁省自然科学基金项目(201102126)
关键词
革兰阳性菌
耐药性
抗菌药物
Gram-positive bacteria
Resistance
Antimicrobial agents